Cresset Asset Management LLC decreased its position in shares of Teradyne, Inc. (NASDAQ:TER - Free Report) by 49.2% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,057 shares of the company's stock after selling 5,876 shares during the period. Cresset Asset Management LLC's holdings in Teradyne were worth $500,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. Berbice Capital Management LLC lifted its holdings in shares of Teradyne by 200.0% in the 1st quarter. Berbice Capital Management LLC now owns 300 shares of the company's stock valued at $25,000 after acquiring an additional 200 shares during the last quarter. Manchester Capital Management LLC lifted its holdings in shares of Teradyne by 44.7% in the 1st quarter. Manchester Capital Management LLC now owns 453 shares of the company's stock valued at $37,000 after acquiring an additional 140 shares during the last quarter. Sentry Investment Management LLC bought a new position in shares of Teradyne in the 1st quarter valued at about $45,000. AdvisorNet Financial Inc lifted its holdings in shares of Teradyne by 319.0% in the 1st quarter. AdvisorNet Financial Inc now owns 595 shares of the company's stock valued at $49,000 after acquiring an additional 453 shares during the last quarter. Finally, Allworth Financial LP lifted its holdings in shares of Teradyne by 36.1% in the 1st quarter. Allworth Financial LP now owns 795 shares of the company's stock valued at $61,000 after acquiring an additional 211 shares during the last quarter. Institutional investors own 99.77% of the company's stock.
Analyst Upgrades and Downgrades
A number of research firms recently weighed in on TER. Morgan Stanley raised shares of Teradyne from an "underweight" rating to an "equal weight" rating and increased their price objective for the stock from $74.00 to $100.00 in a research report on Thursday, July 31st. UBS Group reissued a "buy" rating and issued a $130.00 price objective (up from $120.00) on shares of Teradyne in a research report on Thursday, July 31st. Cowen restated a "buy" rating on shares of Teradyne in a research note on Wednesday, July 30th. The Goldman Sachs Group reaffirmed a "sell" rating and set a $85.00 price target on shares of Teradyne in a research note on Wednesday, July 30th. Finally, Susquehanna dropped their price objective on Teradyne from $155.00 to $133.00 and set a "positive" rating on the stock in a research note on Wednesday, April 30th. One equities research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating, five have given a Hold rating and two have given a Sell rating to the company's stock. According to data from MarketBeat, Teradyne currently has a consensus rating of "Moderate Buy" and a consensus price target of $114.44.
Get Our Latest Analysis on TER
Insiders Place Their Bets
In other Teradyne news, CEO Gregory Stephen Smith sold 554 shares of the business's stock in a transaction that occurred on Tuesday, August 12th. The shares were sold at an average price of $106.00, for a total transaction of $58,724.00. Following the sale, the chief executive officer owned 96,993 shares of the company's stock, valued at approximately $10,281,258. The trade was a 0.57% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.16% of the company's stock.
Teradyne Stock Up 1.3%
Shares of NASDAQ TER traded up $1.54 during trading hours on Tuesday, hitting $118.61. 3,563,515 shares of the stock were exchanged, compared to its average volume of 4,897,054. The company has a market cap of $18.87 billion, a PE ratio of 41.04, a PEG ratio of 2.46 and a beta of 1.72. The firm has a fifty day moving average price of $98.92 and a 200-day moving average price of $91.22. Teradyne, Inc. has a 12 month low of $65.77 and a 12 month high of $144.16.
Teradyne (NASDAQ:TER - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The company reported $0.57 EPS for the quarter, topping the consensus estimate of $0.54 by $0.03. The firm had revenue of $651.80 million during the quarter, compared to analyst estimates of $649.02 million. Teradyne had a net margin of 16.59% and a return on equity of 18.16%. Teradyne's revenue was down 10.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.86 EPS. Teradyne has set its Q3 2025 guidance at 0.690-0.870 EPS. As a group, equities analysts anticipate that Teradyne, Inc. will post 3.88 earnings per share for the current fiscal year.
Teradyne Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Monday, September 29th. Shareholders of record on Friday, September 5th will be given a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 0.4%. The ex-dividend date of this dividend is Friday, September 5th. Teradyne's payout ratio is currently 16.61%.
Teradyne announced that its board has authorized a stock repurchase program on Monday, April 28th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the company to buy up to 8.1% of its shares through open market purchases. Shares buyback programs are often an indication that the company's management believes its shares are undervalued.
Teradyne Company Profile
(
Free Report)
Teradyne, Inc designs, develops, manufactures, and sells automated test systems and robotics products worldwide. It operates through four segments; Semiconductor Test, System Test, Robotics, and Wireless Test. The Semiconductor Test segment offers products and services for wafer level and device package testing of semiconductor devices in automotive, industrial, communications, consumer, smartphones, cloud, computer and electronic game, and other applications.
Featured Stories

Before you consider Teradyne, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teradyne wasn't on the list.
While Teradyne currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.